Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Distribution of cell cycle times amongst the leukemia cells within individual patients with acute myelogenous leukemia.

Preisler HD, Raza A, Gopal V, Ahmad S, Bokhari J.

Leuk Res. 1995 Oct;19(10):693-8.

PMID:
7500644
[PubMed - indexed for MEDLINE]
2.

In vivo cell cycle characteristics of pediatric leukemia patients.

Masterson M, Lampkin B, Yousuf N, Sheikh Y, Raza A.

Exp Hematol. 1992 Nov;20(10):1184-7.

PMID:
1426098
[PubMed - indexed for MEDLINE]
3.

[Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].

Sasaki K, Murakami T, Ogino T, Takahashi M.

Gan No Rinsho. 1985 May;31(5):549-51. Japanese.

PMID:
3860667
[PubMed - indexed for MEDLINE]
4.

In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies.

Raza A, Yousuf N, Bohkari SA, Sheikh Y, Akhtar S, Chughtai S, Umerani A, Mehdi SA, Miller MA, Masterson M, et al.

Leuk Res. 1992;16(3):299-306.

PMID:
1560677
[PubMed - indexed for MEDLINE]
5.

Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics.

Brons PP, Haanen C, Boezeman JB, Muus P, Holdrinet RS, Pennings AH, Wessels HM, de Witte T.

Ann Hematol. 1993 May;66(5):225-33.

PMID:
8507717
[PubMed - indexed for MEDLINE]
6.

Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.

Bertuzzi A, Faretta M, Gandolfi A, Sinisgalli C, Starace G, Valoti G, Ubezio P.

Bull Math Biol. 2002 Mar;64(2):355-84.

PMID:
11926121
[PubMed - indexed for MEDLINE]
7.

Correlation between DNA replication and expression of cyclins A and B1 in individual MOLT-4 cells.

Juan G, Li X, Darzynkiewicz Z.

Cancer Res. 1997 Mar 1;57(5):803-7.

PMID:
9041174
[PubMed - indexed for MEDLINE]
Free Article
8.

Cell cycle kinetics in childhood acute leukemia studied with in vitro bromodeoxyuridine labeling, Ki67-reactivity, and flow cytometry.

Tsurusawa M, Aoyama M, Saeki K, Fujimoto T.

Leukemia. 1995 Nov;9(11):1921-5.

PMID:
7475284
[PubMed - indexed for MEDLINE]
9.

A rapid and simple estimation of cell cycle parameters by continuous labeling with bromodeoxyuridine.

Sasaki K, Murakami T, Takahashi M.

Cytometry. 1987 Sep;8(5):526-8.

PMID:
3311660
[PubMed - indexed for MEDLINE]
10.

Resonance in periodic chemotherapy: a case study of acute myelogenous leukemia.

Andersen LK, Mackey MC.

J Theor Biol. 2001 Mar 7;209(1):113-30.

PMID:
11237575
[PubMed - indexed for MEDLINE]
11.

Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.

Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W.

Clin Cancer Res. 1995 Feb;1(2):169-78.

PMID:
9815970
[PubMed - indexed for MEDLINE]
Free Article
12.

Low proportion of G0-phase cells during induction chemotherapy correlates with subsequent remission in acute myeloid leukemia.

Kamikubo KH, Ogata K, An E, Dan K.

Int J Hematol. 2000 Apr;71(3):249-55.

PMID:
10846830
[PubMed - indexed for MEDLINE]
13.

Comparison of two double labeling techniques to measure cell cycle kinetics in myeloid leukemias.

Yousuf N, Yanik GA, George BA, Masterson M, Mazewski CM, White LM, Miller MA, Lampkin BC, Raza A.

Anticancer Res. 1991 May-Jun;11(3):1195-9.

PMID:
1888149
[PubMed - indexed for MEDLINE]
14.

Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia.

Raza A, Ucar K, Preisler HD.

Cytometry. 1985 Nov;6(6):633-40.

PMID:
3905302
[PubMed - indexed for MEDLINE]
15.

[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].

Pituch-Noworolska A.

Folia Med Cracov. 2001;42(3):5-80. Review. Polish.

PMID:
12353422
[PubMed - indexed for MEDLINE]
16.

[Detection of the resistance to Ara-C blast cells in acute myeloid leukemia using flow cytometry].

Lacombe F, Belloc F, Dumain P, Puntous M, Cony-Makhoul P, Bernard P, Boisseau MR, Reiffers J.

Bull Cancer. 1995;82(5):349-56. French.

PMID:
7626842
[PubMed - indexed for MEDLINE]
17.

Interleukin-9 stimulates the proliferation of human myeloid leukemic cells.

Lemoli RM, Fortuna A, Tafuri A, Fogli M, Amabile M, Grande A, Ricciardi MR, Petrucci MT, Bonsi L, Bagnara G, Visani G, Martinelli G, Ferrari S, Tura S.

Blood. 1996 May 1;87(9):3852-9.

PMID:
8611712
[PubMed - indexed for MEDLINE]
Free Article
18.

Heterogeneity in the HeLa cell cycle response to UVC analyzed by the BrdUrd two-parameter method.

Wang XQ, Ellem KA.

Exp Cell Res. 1994 Jun;212(2):176-89.

PMID:
8187814
[PubMed - indexed for MEDLINE]
19.

A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia.

Kossman SE, Scheinberg DA, Jurcic JG, Jimenez J, Caron PC.

Clin Cancer Res. 1999 Oct;5(10):2748-55.

PMID:
10537338
[PubMed - indexed for MEDLINE]
Free Article
20.

Differences in cell cycle characteristics among patients with acute nonlymphocytic leukemia.

Raza A, Maheshwari Y, Preisler HD.

Blood. 1987 Jun;69(6):1647-53.

PMID:
3555651
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk